OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

Keywords

Computer science

References

• Cooperation between CD4 and CD8 T cells for anti‐tumor activity is enhanced by OX40 signalsAlfredo Montoya Melgar — 2007
• Comment on “CCR7 Is Critically Important for Migration of Dendritic Cells in Intestinal Lamina Propria to Mesenteric Lymph Nodes”David Hume — 2006
• OX40-OX40 Ligand Interaction through T Cell-T Cell Contact Contributes to CD4 T Cell Longevity1Pejman Soroosh, Shouji Ine, Kazuo Sugamura — 2006
• Costimulation of CD8 T Cell Responses by OX401Pratima Bansal‐Pakala, Beth S. Halteman, Mary Cheng — 2004
• A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions1Stephanie K. Lathrop, Cortny A. Huddleston, Per Dullforce — 2004
• Signaling through OX40 (CD134) breaks peripheral T-cell tolerancePratima Bansal‐Pakala, Amha Gebre-Hiwot Jember, Michael Croft — 2001
• Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells1Adam P. Kohm, Jeffrey S. McMahon, Joseph R. Podojil — 2006
• Natural Regulatory T Cells and De Novo-Induced Regulatory T Cells Contribute Independently to Tumor-Specific Tolerance1Gang Zhou, Hyam I. Levitsky — 2007
• OX40 Costimulation Synergizes with GM-CSF Whole-Cell Vaccination to Overcome Established CD8+ T Cell Tolerance to an Endogenous Tumor Antigen1Satoshi Murata, Brian H. Ladle, Peter Kim — 2006
• OX40 Ligand-Transduced Tumor Cell Vaccine Synergizes with GM-CSF and Requires CD40-Apc Signaling to Boost the Host T Cell Antitumor Response1Giorgia Gri, Elena Gallo, Emma Di Carlo — 2003
• Distinct Roles for the OX40-OX40 Ligand Interaction in Regulatory and Nonregulatory T Cells1Ikuo Takeda, Shoji Ine, Nigel Killeen — 2004
• CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.Reinhold Förster, Andreas Schubel, Dagmar Breitfeld — 1999
• Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphaticsShannon K. Bromley, Seddon Y. Thomas, Andrew D. Luster — 2005
• Imaging the function of regulatory T cells in vivo.Qizhi Tang, Matthew F. Krummel — 2006
• Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigensDenise Golgher, Emma Jones, Fiona Powrie — 2002
• OX40 (CD134) engagement drives differentiationof CD4+ T cells to effector cellsCortny A. Huddleston, Andrew D. Weinberg, David C. Parker — 2006
• Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-toleranceJun Shimizu, Sayuri Yamazaki, Takeshi Takahashi — 2002
• Activated T cells express the OX40 ligand: requirements for induction and costimulatory functionItzhak Mendel, Ethan M. Shevach — 2006
• Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10Nicolas Larmonier, Marilyn Marron, Yi Zeng — 2006
• The tumor‐draining lymph node as an immune‐privileged siteDavid H. Munn, Andrew L. Mellor — 2006

Cited by

• Immunomodulating antibodies and drugs for the treatment of hematological malignanciesRoch Houot, Holbrook E. Kohrt, Matthew J. Goldstein — 2011
• OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapyChuji Sakamoto — 2015
• Biology and clinical observations of regulatory T cells in cancer immunology.Michele W.L. Teng, David S. Ritchie, Paul J. Neeson — 2010
• Cancer immunotherapy targeting T cell costimulatory moleculesAngela D. Pardee — 2010
• Development and Partial Characterization of Agonistic OX40 Aptamer anti-CBLB siRNA ConjugatesDawn Seales — 2012
• Cancer immunotherapy: current status and future directions.Fumito Ito, Alfred E. Chang — 2013
• Déviation de l’auto-immunité chez la souris NOD invalidée pour la voie ICOS/ICOSLClaire Briet — 2012
• Regulation of virus-specific T cells in the lung during respiratory virus infectionsRoss B. Fulton — 2010
• The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.Song Guo Zheng — 2008
• Exploitation of costimulatory SA-4-1BBL in the development of therapeutic cancer vaccinesAbhishek Srivastava — 2011
• NEGATIVE REGULATION OF REGULATORY T CELLS BY MYELOID-DERIVED SUPPRESSOR CELLS IN CANCERSara Centuori — 2011
• Functional implications of TNF-receptor pathways on regulatory T cellsXin Chen — 2013
• Cancer immunotherapy in clinical practice—the past, present, and futureGaurav Goel, Weijing Sun — 2014
• OX40, OX40L and Autoimmunity: a Comprehensive ReviewGwilym J. Webb, Gideon M. Hirschfield, Peter J. L. Lane — 2016
• NEGATIVE MODULATION OF REGULATORY T CELLS AND PROMOTION OF THE TUMORICIDAL ACTIVITY OF DENDRITIC CELLS IN CANCER: A DOUBLE-EDGED STRATEGYCollin J. LaCasse — 2011
• Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesPowell Perng, Michael Lim — 2015
• CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40Yongyan Chen, Rui Sun, Xunyao Wu — 2015
• Trial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsAitziber Buqué, Norma Bloy, Fernando Aranda — 2015
• Dysregulation of CD4+CD25hi+ T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritisNalini Vudattu, Klemen Strle, Allen C. Steere — 2013
• Evolving synergistic combinations of targeted immunotherapies to combat cancerIgnacio Melero, David M. Berman, M. Ángela Aznar — 2015

Related papers

No related papers recorded.